IP MONETIZATION: NY - 2013
Stay tuned for the 2014 agenda, speaker and panel information
Check out the 2013 overview below for a representative list of speakers, topics and attendees.
The growth in IP transactions and the media coverage of auctions, sales and settlements has increased the pressure to create stronger ROI from IP assets. Intellectual property is now a vital part of a company's value and a key revenue generator. As a result, IP executives are being held more accountable for the revenue they generate from their portfolios. For IP professionals to succeed, they must look at IP strategically and create a roadmap to harvest their organization's assets.
Last year's event brought together an exclusive group of high-level IP executives for a 360 degree perspective on how best to monetize an IP portfolio.
- Building a monetization strategy
- Evaluation of your IP assets
- Monetization models
- Managing and communicating across your organization
- Selling your IP
- Running a licensing program
- Best enforcement strategies
- Multinational litigation
- Financial reporting of revenues
- Chief IP Counsel
- VP & Director of IP Strategy
- Chief, Deputy and Associate General Counsel
- Intellectual Property, Trademark and Copyright Counsel
- Head of Litigation
- Director of Business and Legal Affairs
- Director/VP of Intellectual Property
- Director/VP of Licensing
- IP Counsel
- Patent Counsel
- VP & Director of Intellectual Asset Management
VP-TS Intellectual Property, Cypress Semiconductor An IP strategist with a combination of technical, business and legal expertise, currently transforming the management of a portfolio of 3000+ patents and applications into a self-funding, business-driven, cross-corporate function delivering entitled ROI. David is also a prolific inventor with over 130 patents granted and pending, and a Patent Agent licensed to practice before the USPTO, reg # 69932. Daivd is responsible for management of a portfolio of ~2000 patents, ~1000 pending applications and the process of IP protection, generation and monetization. Directing systematic review processes to ensure comprehensive and cost-effective protection of strategic IP as it is created. Ensuring maximum ROI on IP$ by implementing systematic reviews of applications against business objectives. Creation, implementation and direction of processes to create and protect strategic IP in emerging technology areas adjacent to existing product lines and technologies.
Dr. Webb received her B.Sc. in Chemistry from the Hebrew University in Jerusalem, her Ph.D. in Chemistry from Columbia University in NY, and her post-doctoral training at Memorial Sloan-Kettering Cancer Center. She is currently Vice President, Intellectual Property at ARMGOâ„¢ Pharma, Inc, a privately held biopharmaceutical company dedicated to the discovery and development of novel small-molecule therapeutics to treat debilitating cardiac, musculoskeletal and neurological disorders. Prior to joining ARMGO, Dr. Webb was at Aton Pharma, Inc., where she was part of a team focused on the discovery of a novel class of histone deacetylase inhibitors leading to the oncology drug SAHA (Vorinostat). She is the recipient of many honors and awards including a Fulbright scholarship. She is also registered patent agent with over 15 years experience in intellectual property portfolio management.
Thelma is Executive Director of Intellectual Property at MannKind Corporation, a publicly traded company headquartered in Valencia, CA with other locations in NJ and CT. Thelma is part of the Danbury, CT office, which also houses R&D and manufacturing facilities. MannKind focuses in developing biopharmaceuticals for pulmonary delivery and cancer immunotherapy. Thelma has been at MannKind since July 2007 and handles almost all aspects of intellectual property for the East Coast sites. She has over 19 years of experience in intellectual property, primarily patent law. Prior to joining MannKind, Thelma worked with the Intellectual Property Groups of three major, global law firms based in New York City, including, Kelley Drye & Warren LLP; Pillsbury Winthrop Shaw Pitman LLC, and White and Case LLP. She began her career at White and Case in the early 90’s and spent over 10 years patent prosecution and participating in many aspects of intellectual property practice. She has a Ph.D. in Anatomy, Cell and Molecular Biology from Hahnemann University School of Medicine and Graduate Studies, now part of Drexel University in Philadelphia. Thelma held the position of Assistant Professor at the Rockefeller University in New York, prior to entering the field of patent law. Thelma is registered to practice before the U.S. Patent and Trademark Office.
Intellectual Property pattern and co-chair Jonathan S. Caplan represents clients in patent litigation, counseling and prosecution, as well as in general corporate matters involving the acquisition, sale or licensing of intellectual property rights.
Jonathan litigates patent infringement actions in federal district courts across the country, in the Court of Appeals for the Federal Circuit, and in state courts, both representing patent owners seeking to enforce their rights and defending companies against allegations of infringement.
-135x135.jpg)
